Baker Avenue Asset Management’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$764K Hold
13,143
0.02% 324
2025
Q4
$606K Hold
13,143
0.01% 333
2025
Q3
$473K Hold
13,143
0.01% 362
2025
Q2
$427K Sell
13,143
-1
-0% -$33 0.01% 322
2025
Q1
$496K Buy
13,144
+1
+0% +$80 0.02% 296
2024
Q4
$1.08M Hold
13,143
0.03% 229
2024
Q3
$1.5M Sell
13,143
-500
-4% -$45.1K 0.05% 208
2024
Q2
$1.03M Hold
13,643
0.04% 221
2024
Q1
$932K Sell
13,643
-137
-1% -$9.49K 0.04% 219
2023
Q4
$865K Hold
13,780
0.04% 218
2023
Q3
$703K Hold
13,780
0.04% 232
2023
Q2
$688K Hold
13,780
0.03% 225
2023
Q1
$516K Sell
13,780
-30
-0.2% -$1.27K 0.03% 257
2022
Q4
$662K Buy
13,810
+30
+0.2% +$1.18K 0.04% 213
2022
Q3
$331K Hold
13,780
0.02% 278
2022
Q2
$300K Hold
13,780
0.02% 266
2022
Q1
$333K Hold
13,780
0.02% 254
2021
Q4
$328K Buy
+13,780
New +$320K 0.02% 256

Other funds holding PCVX